i've talked to a few biotech startups, usually a ceo or founder. the main issues are a consensus in the startup that (1) it's easier to combine numerous unrelated technologies that may not even run in similar environments/platforms to solve a very specific problem, and (2) it doesn't matter their level of skill in applying the tech to solve the very specific problem.